Good Statistical Practice: A Key To Effective and Safe Drug Product
In the pharmaceutical R&D the evaluation procedures play a key role in developing a potent graded product focusing on the various technical advancements it’s easy to overcome hazards.Emphasis is placed on the product’s development to reach specifications of USFDA ,US Pharmacopeia, National Formulary for achieving standards that provide insight on evaluation techniques of drug formulation.Adoption of guidance’s and guidelines cited will strive for achieving good laboratory practice(GLP) good clinical practice(GCP) and good manufacturing practice(cGMP).Embracing statistical approach provides accuracy and reliability of results.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).